Foresite Capital Management II as of March 31, 2016
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 19 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aimmune Therapeutics | 27.2 | $55M | 4.1M | 13.56 | |
| Universal American | 9.8 | $20M | 2.8M | 7.14 | |
| Aduro Biotech | 8.3 | $17M | 1.3M | 12.81 | |
| Epizyme | 7.1 | $14M | 1.2M | 12.12 | |
| Adaptimmune Therapeutics (ADAP) | 7.0 | $14M | 1.8M | 8.13 | |
| Regulus Therapeutics | 6.9 | $14M | 2.0M | 6.93 | |
| Alder Biopharmaceuticals | 6.4 | $13M | 530k | 24.49 | |
| Aerie Pharmaceuticals | 5.7 | $12M | 949k | 12.16 | |
| Nanostring Technologies (NSTGQ) | 4.9 | $10M | 660k | 15.22 | |
| Zafgen | 4.7 | $9.5M | 1.4M | 6.68 | |
| Acceleron Pharma | 2.2 | $4.6M | 174k | 26.39 | |
| Ardelyx (ARDX) | 1.8 | $3.6M | 468k | 7.77 | |
| Orexigen Therapeutics | 1.8 | $3.6M | 6.5M | 0.56 | |
| BioDelivery Sciences International | 1.5 | $3.1M | 953k | 3.23 | |
| Nexvet Biopharma Pub Ltd Co ord | 1.4 | $2.9M | 888k | 3.30 | |
| Anacor Pharmaceuticals In | 1.0 | $2.0M | 31k | 64.39 | |
| Neuroderm Ltd F | 0.8 | $1.7M | 120k | 14.12 | |
| Regenxbio Inc equity us cm (RGNX) | 0.8 | $1.7M | 157k | 10.80 | |
| Scynexis | 0.7 | $1.4M | 337k | 4.03 |
